DEBORAH CASERTA-BRUNSON, MD
Internal Medicine Physician in MILFORD, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
DEBORAH CASERTA-BRUNSON, MD filed 3,448 Medicare Part D claims in 2023 as a Internal Medicine Physician in MILFORD, Connecticut, prescribing 87% generic.
- 3K
- Part D claims, 2023
- 87%
- generic prescribing
- $1.6K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
DEBORAH CASERTA-BRUNSON, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
3,448 Top 10% higher than 90% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
DEBORAH CASERTA-BRUNSON, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about DEBORAH CASERTA-BRUNSON, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Connecticut
How Internal Medicine Physician compares to other specialties among Connecticut providers
Internal Medicine Physician share within Connecticut
Internal Medicine Physician is one of the more visible NUCC categories in Connecticut
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Internal Medicine Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Internal Medicine Physician ABMS/AOA estimate
Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Internal Medicine Physician US NPIs
Specialty board-certified rate — Internal Medicine Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
DEBORAH CASERTA-BRUNSON, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 234 BROAD ST, MILFORD, CT, 06460, with a listed phone of (203) 877-3728. NPI 1659392363 was issued on 07/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CASERTA-BRUNSON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 3,448 prescription claims written by this provider, covering 309 Medicare beneficiaries and totaling roughly $331K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 1.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1659392363 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/21/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm DEBORAH CASERTA-BRUNSON, MD's current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DEBORAH CASERTA-BRUNSON, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.6K
Largest payer
Lilly USA, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
13% brand-name claims vs 87% generic, on 3,448 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 7,590
- Total Day Supply
- 217,079
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $259K
- Generic Drug Cost
- $71K
- Opioid Claims
- 41 (1.2% rate)
- Antibiotic Claims
- 267
Patient Demographics
- Average Patient Age
- 73.4 years
- Avg HCC Risk Score
- 0.93
- Gender Split
- 80% female / 20% male
- Age Distribution
- <65: 25, 65-74: 160, 75-84: 86, 85+: 38
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What DEBORAH CASERTA-BRUNSON, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
255 claims
- Lisinopril
Lisinopril
172 claims
- Atorvastatin Calcium
Atorvastatin Calcium
134 claims
- Amlodipine Besylate
Amlodipine Besylate
122 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
114 claims
- Losartan Potassium 90
Losartan Potassium
90 claims
- Hydrochlorothiazide 84
Hydrochlorothiazide
84 claims
- Lorazepam 76
Lorazepam
76 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 255 |
| Lisinopril | 172 |
| Atorvastatin Calcium | 134 |
| Amlodipine Besylate | 122 |
| Rosuvastatin Calcium | 114 |
| Losartan Potassium | 90 |
| Hydrochlorothiazide | 84 |
| Lorazepam | 76 |
| Azithromycin | 74 |
| Metformin Hcl | 73 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How DEBORAH CASERTA-BRUNSON, MD fits within the Internal Medicine Physician landscape nationally.
DEBORAH CASERTA-BRUNSON, MD's 3,448 claims are above the specialty average of 2,716.
Nearby Internal Medicine Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as CASERTA-BRUNSON.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Connecticut
Frequently Asked Questions
What is DEBORAH CASERTA-BRUNSON, MD's specialty? ▼
How much does DEBORAH CASERTA-BRUNSON, MD prescribe under Medicare Part D? ▼
Where is DEBORAH CASERTA-BRUNSON, MD located? ▼
What is DEBORAH CASERTA-BRUNSON, MD's NPI number? ▼
Does DEBORAH CASERTA-BRUNSON, MD prescribe more brand-name or generic drugs? ▼
Does DEBORAH CASERTA-BRUNSON, MD prescribe opioids? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does DEBORAH CASERTA-BRUNSON, MD prescribe most often? ▼
Does DEBORAH CASERTA-BRUNSON, MD accept Medicare? ▼
How can I verify DEBORAH CASERTA-BRUNSON, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology